Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. In Vivo. 2022 Jul-Aug; 36(4):1615-1627.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Humans
Leukemia, Myeloid, Acute
Mice
Mice, Inbred NOD
Mice, SCID
Pyridones
Sulfonamides
authors with profiles
Olatoyosi Odenike